STONEPINE CAPITAL MANAGEMENT
IS A LIFE-SCIENCE FOCUSED INVESTMENT MANAGEMENT COMPANY
OUR TEAM
JON PLEXICO
MANAGING MEMBER
Has approximately 32 years of life science industry operational and advisory experience, including fourteen years as Principal and Founder of Stonepine. Previously, Mr. Plexico was Managing Director at Merriman Curhan Ford & Co., where he ran healthcare corporate finance focusing on private investments in public equity (PIPEs), secondary offerings, and mergers and acquisitions. Prior to that, Mr. Plexico was co-founding partner of Venture Ready Partners, a life science advisor providing capital raising services to private biotechnology companies. Previously, Mr. Plexico was employee #5 at Chemdex, an electronic life-science commerce company that grew to 500 employees and completed an initial public offering during his tenure. He began his career at Quidel Corporation, where he became National Sales Manager for the Autoimmune Division. He has served on the Boards of Directors of Zila, Inc., Immunetech, Inc., and Viveve Medical, Inc. Mr. Plexico is a graduate of Colgate University.
BRYANT FONG
PARTNER & CO-PORTFOLIO MANAGER
Has approximately 28 years of life science industry research, advisory, operational and venture capital experience. Mr. Fong is a Co-Founder and Managing Partner of Biomark Capital, a life science-focused venture capital firm (which has since rebranded as BCM CT, INC.) that manages the venture fund Biomark Capital Fund IV LP, where he focused on private investments in biotechnology companies. Prior to that, Mr. Fong was Co-Head of Venture Capital and General Partner at Burrill & Company, a life sciences-focused investment firm where he helped build assets under management to over $1 billion and managed a team of sixteen investment professionals. At Burrill, Mr. Fong focused on venture capital investments in the life sciences and as well as private equity investments in public equity (PIPEs) and secondary offerings. Mr. Fong served and continues to serve on the Boards of Directors of numerous private and public life science companies including ADMA Biologics. Mr. Fong is an honors graduate in biochemistry of University of California at Berkeley.
JEFFREY NUNNENKAMP
COO
Joined Stonepine Capital Management LLC as Chief Operating Officer and Chief Compliance Officer in 2017. Prior to joining Stonepine, Mr. Nunnenkamp was Vice President of Alternative Funds Finance at PIMCO with responsibility for hedge funds finance and operations. With over 20 years relevant experience, his previous positions include Manager of fixed income portfolio accounting at Wells Capital Management, Second Vice President at Northern Trust where he managed the hedge fund administration group, and Supervisor of global portfolio administration at Western Asset Management. He holds an MBA in finance from Loyola Marymount University, a BBA in Marketing Management from the University of Portland, and is a Certified Public Accountant and Investment Advisor Certified Compliance Professional.
MATT CARROLL
DIRECTOR OF RESEARCH
Joined Stonepine Capital Management LLC in 2012 and serves as Director of Research. In this capacity Mr. Carroll leads internal and external research on prospective investments utilizing his twelve years of investment experience at Stonepine to identify and evaluate life science investment opportunities with a particular emphasis on commercial-stage companies. Prior to joining Stonepine, Mr. Carroll specialized in accounting, finance, and tax matters, ultimately co-founding Tyler & Carroll LLP, a CPA firm offering finance and accounting services to individuals and small businesses. Mr. Carroll holds a bachelor's degree in business with an emphasis in accounting from Linfield College and is a Certified Public Accountant (inactive).
JENNIFER ARRUDA
CCO
Joined Stonepine Capital Management LLC as the Manager of Accounting & Operations in 2017. Prior to joining Stonepine, Mrs. Arruda served as the Controller for Hart, Inc, a healthcare software company. Previously, she held a Senior Associate role in the Assurance practice with PricewaterhouseCoopers, LLC, where she specialized in integrated audits of multi-national public companies. Mrs. Arruda is a Certified Public Accountant and holds a Bachelor of Science in Accounting and Bachelor of Administration in Finance from Loyola Marymount University.
KENNY STORCH
SENIOR INVESTMENT ANALYST
Joined Stonepine Capital Management LLC in 2023 as a Senior Investment Analyst. Prior to joining Stonepine, Mr. Storch was a Healthcare Sector Specialist at BTIG where he advised institutional investor clients and management teams across the private and public healthcare sector on investment opportunities, competitive landscapes, business development prospects, and assisted with the firm’s sales, trading, research, and capital markets efforts. His previous positions include research and investor relations roles at Urogen Pharma and Kite Pharma. Mr. Storch holds a bachelor’s degree in chemistry with minors in corporate strategy and financial economics from Vanderbilt University.
CONTACT US
​
OUR ADDRESS
For any general inquiries, please fill in the following contact form: